2. Gene
  3. Acly - ATP citrate lyase Gene

Acly - ATP citrate lyase Gene

  • 基因
  • 蛋白
  • 相关产品
  • 直系同源

中文名称：ATP柠檬酸裂解酶

种属: Mus musculus

同用名: A730098H14Rik

基因 ID: 104112 | 基因类型: protein coding

关于 Acly

Chromosome 11: 100,367,179-100,418,826 reverse strand.GRCm39:CM001004.3

This gene has 7 transcripts (splice variants), 283 orthologues and is associated with 2 phenotypes. Broad expression in subcutaneous fat pad adult (RPKM 333.), mammary gland adult (RPKM 298.7) and 24 other tissues.

功能概要

该基因编码的蛋白可启动 ATP 柠檬酸合酶活性。预计参与乙酰辅酶A生物合成过程和羧酸代谢过程。预计在脂质代谢过程的上游或内部起作用。位于线粒体中。以多种结构表达，包括消化系统；泌尿生殖系统；神经系统;呼吸系统;和感觉器官。与人类 ACLY（ATP 柠檬酸裂解酶）同源。 [由基因组资源联盟提供，2022 年 4 月]

Enables ATP citrate synthase activity. Predicted to be involved in acetyl-CoA biosynthetic process and carboxylic acid metabolic process. Predicted to act upstream of or within lipid metabolic process. Located in mitochondrion. Is expressed in several structures, including alimentary system; genitourinary system; nervous system; respiratory system; and sensory organ. Orthologous to human ACLY (ATP Citrate Lyase). [provided by Alliance of Genome Resources, Apr 2022]

Acly 基因产物(2)

mRNA Protein Name
NM_001199296.1 NP_001186225.1 ATP-citrate synthase isoform 1
NM_134037.3 NP_598798.1 ATP-citrate synthase isoform 2
基因本体论
  • 分子功能
分子功能 GO 注释 逻辑证据 参考文献 来源
enables ATP citrate synthase activity IDA
IDA: 通过直接分析推断
25450640 MGI
enables protein binding IPI
IPI: 通过物理相互作用推断
15102471 MGI
EXP：通过实验结果推断 IDA：通过直接分析推断 IPI：通过物理相互作用推断 IMP：通过突变表型推断 IGI：通过遗传相互作用推断 IEP：通过表达模式推断

Acly 蛋白结构

PLN02235

PLN02235: cl42902 (0 - 418)

PLN02522

PLN02522: cl31895 (478 - 1083)

  • 0
  • 200
  • 400
  • 600
  • 800
  • 1000
  • 1091 a.a.
蛋白主名 其他名称

ATP-citrate synthase

ATP-citrate (pro-S-)-lyase

citrate cleavage enzyme

相关产品

Approval
生物活性分子 (9)
目录号 产品名 作用方式
纯度 是否罕见病
HY-13001 Quizartinib 99.08% 是
HY-109539 Gemtuzumab ozogamicin Inducer 98.00% 否
HY-B0091 Adapalene 99.98% 是
HY-14217 Quizartinib dihydrochloride 99.81% 否
HY-B0393 Fudosteine ≥98.0% 否
HY-B0491A Carbazochrome sodium sulfonate ≥98.0% 否
HY-14277A Levocabastine hydrochloride Antagonist 99.3% 否
HY-B0091R Adapalene (Standard) / 否
HY-B0091A Adapalene sodium salt / 否
抗体抑制剂 (1)
目录号 产品名 作用方式
纯度 是否罕见病
HY-P9959 Inotuzumab ozogamicin / 否
Clinical Phase
生物活性分子 (10)
目录号 产品名 作用方式
纯度 Phase
HY-156655A Olgotrelvir sodium Inhibitor ≥95.0% Phase 3
HY-156655 Olgotrelvir Inhibitor / Phase 3
HY-15527 Emapunil Inhibitor 99.94% Phase 2
HY-13535 ATN-161 Antagonist 99.36% Phase 2
HY-106025 Radequinil Antagonist 99.25% Phase 2
HY-P1454 Fz7-21 Antagonist 99.59% Phase 1
HY-12010 BMS-599626 Hydrochloride Inhibitor 99.68% Phase 1
HY-144289 BMS-820132 Activator 99.75% Phase 1
HY-10251 BMS-599626 Inhibitor / Phase 1
HY-132824 Ledaborbactam etzadroxil Inhibitor / Phase 1
抗体抑制剂 (3)
目录号 产品名 作用方式
纯度 Phase
HY-P990012 Vamikibart Inhibitor ≥99.0% Phase 3
HY-P99362 Ensituximab Inhibitor 99.93% Phase 2
HY-P9992 Pelgifatamab Inhibitor 99.86% Phase 1
Pre-clinical Phase
生物活性分子 (456)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-18657 TEPP-46 Activator 99.93% 否
HY-118297 Ac4ManNAz (80% α isomer) 99.74% 否
HY-16990 Ac-YVAD-cmk Inhibitor 98.94% 否
HY-16450 SB 204990 Inhibitor 99.75% 否
HY-100396 SQ22536 Inhibitor 99.98% 否
HY-44134 Dimethyl 2-oxoglutarate Inhibitor 97.50% 否
HY-W728531 Ac4ManNAz Inhibitor 99.52% 否
HY-P1001 Ac-DEVD-CHO Inhibitor 99.76% 否
HY-P1098 Ac2-26 Inhibitor 99.14% 否
HY-104032 Ac-CoA Synthase Inhibitor1 Inhibitor 99.70% 否
HY-110288 3FAx-Neu5Ac 99.88% 否
HY-101801 Ac-Gly-BoroPro ≥98.0% 否
HY-133870 Itaconate-alkyne 98.01% 否
HY-124500 AC-4-130 99.93% 否
HY-141128 Ac4GalNAz 99.99% 否
HY-127111 NDI-091143 Inhibitor 99.72% 否
HY-15967 PS48 Activator 99.71% 否
HY-122214 AC-73 Inducer 99.84% 否
HY-P1098A Ac2-26 TFA Inhibitor 99.67% 否
HY-Y1977 100mM Pro-Ac, 20 mM Arg, pH 5.0 buffer 99.29% 否
HY-112942A CMP-Sialic acid sodium salt 92.51% 否
HY-111675 Ac-FLTD-CMK Inhibitor 99.53% 否
HY-125798 2,3-Dehydro-2-deoxy-N-acetylneuraminic acid Inhibitor ≥99.0% 否
HY-107636 DC_AC50 Inducer 99.97% 否
HY-P1003 Ac-DEVD-AMC 99.93% 否
HY-149302 MC4033 98.26% 否
HY-145765 JQAD1 98.24% 否
HY-100958 4-DAMP 99.96% 否
HY-P1005 Ac-DEVD-AFC 99.59% 否
HY-124004 Acetyl-6-formylpterin ≥95.0% 否
HY-101279 ST034307 Inhibitor 99.11% 否
HY-138159 Boc-Lys(Ac)-AMC 99.53% 否
HY-100738 Ubiquitin Isopeptidase Inhibitor I, G5 Inducer ≥98.0% 否
HY-120019 Ac-YVAD-CHO Inhibitor 98.23% 否
HY-122051 AC1903 Inhibitor 99.80% 否
HY-103430A SKF-83566 Antagonist 99.86% 否
HY-N2609 7,4'-Dihydroxyflavone Inhibitor 99.68% 否
HY-141866 Acid Ceramidase-IN-1 99.36% 否
HY-P3236 N-Acetyl-Ile-Glu-Pro-Asp-p-nitroanilide 99.77% 否
HY-136744 Caspase-9 Inhibitor III Inhibitor 99.00% 否
HY-154818 Bovine Serum Albumin, Acetylated / 否
HY-P1006 Ac-DEVD-pNA Substrate 98.96% 否
HY-P1169 Ac-IETD-AFC 99.91% 否
HY-P1393A AC 187 TFA 99.40% 否
HY-147368 PKM2 activator 2 Activator 99.48% 否
HY-123052 Ac-PAL-AMC ≥98.0% 否
HY-14350 AC-55541 Agonist 99.40% 否
HY-160109 Ac5GalNTGc 98.39% 否
HY-W014130 N-Acetyl-L-arginine 99.97% 否
HY-P0034A Ac-DEVD-CMK TFA Inhibitor 99.07% 否
HY-P10149 Ac-IEPD-CHO Inhibitor 99.61% 否
HY-P1093 Ac-LEHD-AFC 98.22% 否
HY-P2377 Ac-YVAD-AFC 99.56% 否
HY-123051 Ac-WLA-AMC 99.79% 否
HY-P1092 Ac-IEPD-AFC 99.97% 否
HY-79490 Ac-Exatecan Inhibitor 98.70% 否
HY-P2091 Ac-YVAD-pNA 99.93% 否
HY-W004066 Ac-Ala-OH ≥98.0% 否
HY-W039953 Ac4GlcNAz 96.86% 否
HY-P2617A Ac-WEHD-AFC TFA 99.01% 否
HY-111554 AcLys-PABC-VC-Aur0101 Inhibitor 98.49% 否
HY-123630 Allura Red AC 98.01% 否
HY-147286 Ac-Lys-Val-Cit-PABC-MMAE 99.94% 否
HY-N2098 Obtusifolin Inhibitor 99.91% 否
HY-148859 AA-T3A-C12 99.76% 否
HY-103195 NKY80 Inhibitor 99.76% 否
HY-151852 9AzNue5Ac ≥95.0% 否
HY-153750 Wnt pathway inhibitor 3 Inhibitor 98.96% 否
HY-32264 X-Neu5Ac sodium Inhibitor 99.98% 否
HY-W008986 Fmoc-Lys(Ac)-OH 99.79% 否
HY-P4417A Ac-IEPD-AMC TFA 98.01% 否
HY-W102456 H-Phe(4-Ac)-OH 99.19% 否
HY-132197 CBP/p300-IN-12 Inhibitor 99.72% 否
HY-116874 SKF 83822 Agonist 98.66% 否
HY-160821A N-Acetylmannosamine 6-phosphate sodium salt ≥95.0% 否
HY-D1705 Ac-ANW-AMC 99.40% 否
HY-P1368A Stressin I TFA Agonist 98.38% 否
HY-P1454A Fz7-21 TFA Antagonist 99.35% 否
HY-P5247 Palmitoyl tetrapeptide-20 Activator 99.67% 否
HY-N9459 2-Amino-2-deoxyglucose hydrochloride ≥98.0% 否
HY-122025 AC-262536 Agonist 99.94% 否
HY-146356 Adenylyl cyclase type 2 agonist-1 Agonist 99.30% 否
HY-147117 NHS-SS-Ac ≥95.0% 否
HY-P1393 AC 187 98.86% 否
HY-P3434A Ac-FEID-CMK TFA Inhibitor 97.06% 否
HY-108526 AC-55649 Agonist 99.70% 否
HY-108532 AC-261066 Agonist 99.27% 否
HY-14351 AC-264613 Agonist 98.3% 否
HY-158123 PSMA binder-1 98.33% 否
HY-P1368 Stressin I Agonist 98.20% 否
HY-P2016 Ac-Nle-Pro-Nle-Asp-AMC 99.85% 否
HY-P2462 Ac-Arg-Gly-Lys(Ac)-AMC 99.27% 否
HY-W011982 Ac-DL-Trp-OH 99.49% 否
HY-116530 9-Cyclopentyladenine monomethanesulfonate Inhibitor 99.16% 否
HY-124680 AC-263093 free base Inhibitor 99.81% 否
HY-161024 AC1Q3QWB Inhibitor 99.39% 否
HY-P3662 Ac-[Nle4,D-Phe7]-α-MSH (4-10)-NH2 Activator 99.50% 否
HY-120833 Ac-Ile-Glu-Thr-Asp-pNA 99.90% 否
HY-125604 WCK-4234 Inhibitor ≥98.0% 否
HY-138586 DMT-dC(ac) Phosphoramidite Activator 99.76% 否
HY-144549 LXR agonist 1 Agonist 99.95% 否
HY-148043 Schnurri-3 inhibitor-1 Inhibitor 99.07% 否
HY-148324 PKM2 activator 5 Activator 96.24% 否
HY-66007 Ac-β-Ala-OH ≥98.0% 否
HY-150248 RNA splicing modulator 3 Modulator 98.58% 否
HY-P10639 C5aR2 agonist P32 Agonist 99.82% 否
HY-P4449A Ac-VRPR-AMC TFA 99.69% 否
HY-115748 Mant-GTPγS Inhibitor ≥93.0% 否
HY-117851 AC-265347 Agonist 99.97% 否
HY-13856 (R)-PS210 Inhibitor 98.09% 否
HY-14425 Peturadol Inhibitor 98.7% 否
HY-145830 AC1-IN-1 Inhibitor 99.32% 否
HY-158118 Lys(CO-C3-p-I-Ph)-OMe 97.19% 否
HY-D1652 Ac-LEHD-AMC Chemical 98.96% 否
HY-P0232 Fmoc-Thr[GalNAc(Ac)3-α-D]-OH 99.53% 否
HY-P1448 Ac-Leu-Arg-AMC 98.17% 否
HY-P4764 Ac-(d-Arg)-CEH-(d-Phe)-RWC-NH2 Agonist 99.09% 否
HY-W016749 N-Acetyl-DL-aspartic acid 99.93% 否
HY-151819 N3Ac-OPhOMe 98.21% 否
HY-18700 BRD73954 Inhibitor ≥98.0% 否
HY-21648 2'-OMe-Ac-C Phosphoramidite 99.53% 否
HY-45491 Dmt-2'-f-dc(ac) amidite 99.7% 否
HY-W077279 5'-O-DMT-N4-Ac-dC 97.16% 否
HY-153094 BDM-2 Inhibitor 99.09% 否
HY-100336 AC260584 Agonist 99.60% 否
HY-103688 N-Ac-γ-Calicheamicin-AcBut-NHS ester 95.62% 否
HY-108312A Ac-VEID-CHO TFA Inhibitor 98.7% 否
HY-110157 AC-186 Agonist 99.61% 否
HY-138614 5'-O-DMT-2'-O-TBDMS-Ac-rC 99.80% 否
HY-141464 Fmoc-L-Asn(beta-D-GlcNAc(Ac)3)-OH 95.03% 否
HY-144287 Glucokinase activator 3 Activator 98.36% 否
HY-148041 ATPase-IN-2 Inhibitor ≥98.0% 否
HY-151516 microRNA-21-IN-2 Inhibitor ≥98.0% 否
HY-170534 Ac-EEVC-OH / 否
HY-N10772 Albanin A Inhibitor 97.67% 否
HY-P0266B N-Acetyl-Ser-Asp-Lys-Pro acetate 99.88% 否
HY-P0280 MUC5AC motif peptide 98.79% 否
HY-P10142 Ac-YEVD-AMC 99.59% 否
HY-P10201A Ac-GpYLPQTV-NH2 acetate Inhibitor 99.38% 否
HY-P10235 Cyclic AC253 Antagonist 99.87% 否
HY-P1098B Ac2-26 ammonium Degrader 97.45% 否
HY-P1118 Ac9-25 99.62% 否
HY-P3115 Ac-LEVD-AFC 98.11% 否
HY-P3155 Ac-hMCH(6-16)-NH2 Agonist 99.94% 否
HY-P3455 Ac-SVVVRT-NH2 Modulator 98.68% 否
HY-P5983 Ac-VEID-AFC 99.26% 否
HY-P6079A Ac-IHIHIYI-NH2 TFA 99.02% 否
HY-W024554 AC-Asp(OtBU)-OH 99.48% 否
HY-W096146 Propynyl-PEG1-Ac ≥95.0% 否
HY-13493 AC710 Inhibitor 99.13% 否
HY-158783 SACLAC 99.70% 否
HY-164054 MicroRNA modulator-2 Modulator 99.54% 否
HY-W114328 DMT-OMe-rC(Ac) ≥97.0% 否
HY-132934 Ac32Az19 Inhibitor 99.50% 否
HY-P6825 PNT2001 Ligand 98.72% 否
HY-103430 SKF-83566 hydrobromide Antagonist / 否
HY-112942 CMP-Sialic acid / 否
HY-115748A Mant-GTPγS triammonium Inhibitor / 否
HY-118343 AC-93253 Inhibitor 99.3% 否
HY-124609 CAD031 99.39% 否
HY-125501 Biotin-XX hydrazide 95.43% 否
HY-134567A Ac-VDVAD-CHO TFA Inhibitor 99.15% 否
HY-136727 Ac-LEVD-CHO Inhibitor 98.41% 否
HY-138602 5'-O-DMT-N4-Ac-2'-F-dC 99.11% 否
HY-138612 5'-O-DMT-3'-O-TBDMS-Ac-rC 99.18% 否
HY-147286A Ac-Lys-Val-Cit-PABC-MMAE formic 99.96% 否
HY-150246 RNA splicing modulator 1 Modulator / 否
HY-153613 Ac-PLVE-FMK Inhibitor ≥98.0% 否
HY-158125 PSMA binder-2 97.35% 否
HY-160109A Ac5GalNTGc epimer Inhibitor 98.39% 否
HY-D1258 AC-green 98.04% 否
HY-P10145 Ac-LEVD-pNA 99.17% 否
HY-P10781 PSMA-D5 Modulator 98.61% 否
HY-P3761 Ac-Tyr-Val-Lys-Asp-aldehyde Inhibitor 99.89% 否
HY-P4417 Ac-IEPD-AMC / 否
HY-P4449 Ac-VRPR-AMC / 否
HY-P4547 Ac-Trp-Glu-His-Asp-AMC 99.84% 否
HY-P4846 Ac-Pro-Gly-Pro-OH Agonist 99.49% 否
HY-P5247A Palmitoyl tetrapeptide-20 TFA Activator / 否
HY-W012713 Ac-D-Ala-OH ≥98.0% 否
HY-W114327 N4-Acetyl-2'-O-methylcytidine ≥98.0% 否
HY-W145561 Neu5Acα(2-3)Galβ MP glycoside 99.43% 否
HY-W145646 Fmoc-L-Ser((Ac)4-β-D-Glc)-OH ≥98.0% 否
HY-W570884 5-Me-dC(Ac) amidite ≥97.0% 否
HY-118806A AC-42 hydrochloride Agonist 98.42% 否
HY-154829A AC-099 hydrochloride Agonist 99.92% 否
HY-156287 GCase modulator-1 Modulator ≥97.0% 否
HY-16020 AC-430 hydrobromide Inhibitor 99.70% 否
HY-163820 WIZ degrader 4 Degrader 99.37% 否
HY-164248 Ac-rG 99.69% 否
HY-W101366 AC-PHE-OME 99.87% 否
HY-13001S Quizartinib-d8 / 否
HY-163608 Ac-macropa / 否
HY-B0091S Adapalene-d3 / 否
HY-101863 CB-6673567 Inhibitor / 否
HY-103411 SKF83822 hydrobromide Agonist / 否
HY-106530 Gitoformate / 否
HY-106560 Proglumetacin Inhibitor / 否
HY-113844A Ac-Gly-Lys-OMe acetate / 否
HY-113963 Ac-​IETD-​CHO Inhibitor / 否
HY-117118A AC-90179 Agonist / 否
HY-117616 Laurotetanine Inhibitor / 否
HY-117867A AVE-8063 hydrochloride / 否
HY-118464 AC915 / 否
HY-118806 AC-42 Agonist / 否
HY-120019A Ac-YVAD-CHO acetate Inhibitor / 否
HY-121738 TC AC 28 Inhibitor / 否
HY-125673 AC-178335 / 否
HY-126232 Verproside / 否
HY-128433 CK1-IN-3 Inhibitor 99.00% 否
HY-134567 Ac-VDVAD-CHO Inhibitor / 否
HY-134684 Mal-PEG3-O-Ac / 否
HY-135020 AC-24,055 / 否
HY-135070 Ac-RLR-AMC / 否
HY-135070B Ac-RLR-AMC TFA / 否
HY-135244 Imazamethabenz-methyl / 否
HY-135392S N-Desmethyl Pimavanserin-d9 hydrochloride / 否
HY-136666 Antibiotic AC4437 Inhibitor / 否
HY-136728 Ac-YVAD-AOM Inhibitor / 否
HY-136733 Ac-DNLD-CHO Inhibitor / 否
HY-137918 TGF-βRI inhibitor 3 Inhibitor / 否
HY-138583 Ac-dA Phosphoramidite / 否
HY-140343 Ac4GalNAl / 否
HY-141077 N-(Ac-PEG3)-N'-(azide-PEG3)-Cy7 chloride / 否
HY-141127 Azido-PEG4-tetra-Ac-beta-D-glucose / 否
HY-14277 Levocabastine Antagonist / 否
HY-143463 AC-386 Inhibitor / 否
HY-147397 PKM2 activator 3 Activator / 否
HY-148313 PKM2 activator 4 Activator / 否
HY-148415 Ac-Phe-Gly-pNA / 否
HY-149552 Ac4-5SGlcNAc / 否
HY-150658S DMT-2′O-TBDMS-rA(ac)-1-15N phosphoramidite / 否
HY-153614 Ac-VLPE-FMK Inhibitor ≥99.0% 否
HY-154213 5’-O-DMTr-5-MedC (Ac)-methyl phosphonamidite / 否
HY-154592 DMTr-TNA-G(O6-CONPh2)(N2Ac)-amidite / 否
HY-155229 CBP/p300-IN-21 Inhibitor / 否
HY-156020 Glucocerebrosidase-IN-2 Inhibitor / 否
HY-158119A PSMA-trillium / 否
HY-158776 SLU-10482 Inhibitor / 否
HY-159095 PKR activator 5 Activator / 否
HY-159593 Ac-NH-(S,R,S)-AHPC-CO-cyclohexane-pyrimidine-diazabicyclo / 否
HY-159601 CSN5-IN-1 Inhibitor / 否
HY-161160 Ac4ManNDAz / 否
HY-161519 PKM2 activator 7 Activator / 否
HY-162665 WIZ degrader 1 Inducer / 否
HY-162689 GprA Agonist / 否
HY-162837 AURKA against 1 Inhibitor / 否
HY-163818 WIZ degrader 2 Degrader / 否
HY-163819 WIZ degrader 3 Degrader / 否
HY-163951 (S,R,S)-AHPC-Ac / 否
HY-163952 (S,R,S)-AHPC-Ac-CO-cyclohexene-Bpin / 否
HY-168656 Ac-Atovaquone Inhibitor / 否
HY-169263 AC10142A Inhibitor / 否
HY-169824 TRPML modulator 1 Inducer / 否
HY-170841 HDAC3/BRD4-IN-1 Inhibitor / 否
HY-171279 Casein kinase 1δ-IN-29 / 否
HY-171960 SHP2-IN-40 Inhibitor / 否
HY-172914 ACLY-IN-1 Inhibitor / 否
HY-173135 PROTAC KDM4 degrader-1 / 否
HY-173374 DOTAGA-FAP-2286-ALB Inhibitor / 否
HY-174151 XSJ110 / 否
HY-174216 PZL-A Activator / 否
HY-176060 Platelet aggregation-IN-3 Ligand / 否
HY-176063 TRPV1 antagonist 11 / 否
HY-177062 NPRA agonist-11 Agonist / 否
HY-18234B Leupeptin Ac-LL Inhibitor / 否
HY-18234C Leupeptin Ac-LL hydrochloride Inhibitor / 否
HY-48668 AcLys-PABC-VC-Aur0101 intermediate-1 / 否
HY-79490S Ac-Exatecan-d5 Inhibitor 99.93% 否
HY-D2379A closed-HMRG / 否
HY-D2869 Ac-H-FluNox / 否
HY-E70019 alpha-2-3,6-sialidase (BiNanH2) / 否
HY-E70445 Chondroitinase AC II / 否
HY-N10628 Neu5Acα(2-6) N-Glycan / 否
HY-N8356 13-cis-Vitamin A palmitate / 否
HY-N8356A 9-cis-Vitamin A palmitate / 否
HY-P0034 Ac-DEVD-CMK Inhibitor / 否
HY-P0211 [Ac-Tyr1,D-Phe2]GRF 1-29, amide (human) Antagonist / 否
HY-P1001A Ac-DEVD-CHO TFA / 否
HY-P10070 Ac-pSar16-OH / 否
HY-P10082 Ac-VETD-AMC / 否
HY-P10083 Ac-VQVD-pNA / 否
HY-P10084 Ac-VAD-pNA / 否
HY-P10144 Ac-Orn-Phe-Arg-AMC / 否
HY-P10146 Ac-LETD-CHO Inhibitor / 否
HY-P10147 Ac-LDESD-AMC Inhibitor / 否
HY-P10161 Ac-DMQD-pNA / 否
HY-P10162 Ac-DMQD-AMC / 否
HY-P10175 Acetalin-1 Antagonist / 否
HY-P10176 Acetalin-2 / 否
HY-P10177 Acetalin-3 Antagonist / 否
HY-P10201 Ac-GpYLPQTV-NH2 Inhibitor / 否
HY-P10215 Ac-{Cpg}-Thr-Ala-{Ala(CO)}-Asp-{Cpg}-NH2 Inhibitor / 否
HY-P10231 Ac-Phe-Thiaphe-OH / 否
HY-P10236 Ac-WEHD-pNA / 否
HY-P10240 Ac-WVAD-AMC / 否
HY-P10241 Ac-LEHD-CHO Inhibitor / 否
HY-P10243 Ac-VAD-CMK Inhibitor / 否
HY-P10244 Ac-YVAD-FMK Inhibitor / 否
HY-P10276 Ac-VAD-AFC / 否
HY-P10452 Ac-LEVDGWK(Dnp)-NH2 / 否
HY-P10656 Ac-DEVDD-TPP Inducer / 否
HY-P10667 Ac-MRGDH-NH2 / 否
HY-P10706 Ac-ILVAGK-NH2 / 否
HY-P10816 PACE4 Inhibitory peptide C23 / 否
HY-P10939 Ac-DMLD-CMK Inhibitor / 否
HY-P10955 Ac-AAVALLPAVLLALLAPVAD-CHO TFA Inhibitor / 否
HY-P1118A Ac9-25 TFA / 否
HY-P1200 Ac-Tyr(PO3H2)-Glu-Glu-Ile-Glu-OH Inhibitor / 否
HY-P1200A Ac-Tyr(PO3H2)-Glu-Glu-Ile-Glu-OH TFA Inhibitor / 否
HY-P1316 Ac-RYYRWK-NH2 Antagonist / 否
HY-P1316A Ac-RYYRWK-NH2 TFA Agonist / 否
HY-P1318 Ac-RYYRIK-NH2 Agonist / 否
HY-P1318A Ac-RYYRIK-NH2 TFA Agonist / 否
HY-P2065 Ac-VEID-AMC / 否
HY-P2285 AC 253 Antagonist / 否
HY-P2374 Ac-DMQD-CHO Inhibitor / 否
HY-P2413 Ac-PPPHPHARIK-NH2 Inhibitor / 否
HY-P2610 Ac-VEID-pNA Activator / 否
HY-P2615 Ac-VDVAD-AFC / 否
HY-P2615A Ac-VDVAD-AFC TFA / 否
HY-P2620 Ac-LETD-AFC / 否
HY-P2633A Dentonin TFA / 否
HY-P2717 Ac-YVAD-AMC Inhibitor / 否
HY-P2939 Chondroitinase AC / 否
HY-P2977 N-Acetylneuraminate lyase (CgNal) / 否
HY-P3110 Ac-DNLD-AMC / 否
HY-P3307 Ac-Val-Gln-aIle-Val-aTyr-Lys-NH2 / 否
HY-P3362 Ac-IETD-AMC / 否
HY-P3364 Ac-QPKK(Ac)-AMC / 否
HY-P3434 Ac-FEID-CMK Inhibitor / 否
HY-P3690 Ac-Leu-Leu-Norleucinol Inhibitor / 否
HY-P3729 Ac-Lys-D-Ala-D-Ala-OH / 否
HY-P3940 Ac-MBP (4-14) Peptide / 否
HY-P4019 Ac-Ser-Gln-Asn-Tyr-Pro-Val-Val-NH2 / 否
HY-P4039 Ac-EEVVAC-pNA / 否
HY-P4040 Ac-D-DGla-LI-Cha-C Inhibitor / 否
HY-P4408 Ac-Arg-Gly-Lys-AMC / 否
HY-P4416 Ac-Gly-Ala-Lys(Ac)-AMC / 否
HY-P4443 Ac-GAK-AMC / 否
HY-P4448 Ac-Gly-Pro-AFC / 否
HY-P4519 Ac-Lys(Ac)-D-Ala-D-Lactic acid Substrate / 否
HY-P4521 Ac-Pro-Leu-Gly-[(S)-2-mercapto-4-methyl-pentanoyl]-Leu-Gly-OEt / 否
HY-P4532 Ac-Leu-Val-Lys-Aldehyde Inhibitor / 否
HY-P4535 Ac-Trp-Glu-His-Asp-Aldehyde Inhibitor / 否
HY-P4688 (Ser(Ac)4,D-Ser(tBu)6,Azagly10)-LHRH / 否
HY-P4787 Ac-Glu-Asp(EDANS)-Lys-Pro-Ile-Leu-Phe-Phe-Arg-Leu-Gly-Lys(DABCYL)-Glu-NH2 / 否
HY-P4832 Acetyl-Tau Peptide (273-284) amide Inhibitor / 否
HY-P5045 Fmoc-Thr(GalNAc(Ac)3-β-D)-OH / 否
HY-P5280 Ac-KQL-AMC / 否
HY-P5378 Ac-KQKLR-AMC / 否
HY-P5525 AC3-I, myristoylated Inhibitor / 否
HY-P5922 PTD2 Inhibitor / 否
HY-P5936 Ac-AAVALLPAVLLALLAP-DEVD-CHO Inhibitor / 否
HY-P5938 Ac-AAVALLPAVLLALLAP-YVAD-CHO Inhibitor / 否
HY-P5955 Ac-AAVALLPAVLLALLAP-LEVD-CHO Inhibitor / 否
HY-P5956 Ac-AAVALLPAVLLALLAP-LEHD-CHO Inhibitor / 否
HY-P6079 Ac-IHIHIYI-NH2 / 否
HY-R01635 hsa-miR-548ac mimic / 否
HY-R01635A hsa-miR-548ac agomir / 否
HY-RI01635 hsa-miR-548ac inhibitor / 否
HY-RI01635A hsa-miR-548ac antagomir / 否
HY-RS00166 ACLY Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS00167 Acly Mouse Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS00168 Acly Rat Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS05088 FRA10AC1 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS05955 H2AC18 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS08844 MUC5AC Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-W004066S Ac-Ala-OH-d3 ≥99.0% 否
HY-W004066S1 Ac-Ala-OH-d4 / 否
HY-W010389S2 Ac-DL-Ala-OH-d4 / 否
HY-W011254 Ac-VAD-CHO Inhibitor / 否
HY-W012713S Ac-D-Ala-OH-d4 ≥99.0% 否
HY-W013322 Ac-Tyr-OEt.H2O ≥98.0% 否
HY-W014130A N-Acetyl-L-arginine dihydrate / 否
HY-W015241 Ac-D-Glu-OH / 否
HY-W015241S Ac-D-Glu-OH-d5 ≥99.0% 否
HY-W016584 4,5-Dichlorocatechol Inhibitor / 否
HY-W040802 AC-94149 ≥90.0% 否
HY-W042357S Ac-rC Phosphoramidite-15N / 否
HY-W042357S1 Ac-rC Phosphoramidite-15N2 / 否
HY-W042357S2 Ac-rC Phosphoramidite-15N3 / 否
HY-W042357S3 Ac-rC Phosphoramidite-13C2,d1 / 否
HY-W042357S4 Ac-rC Phosphoramidite-13C9 / 否
HY-W042357S5 Ac-rC Phosphoramidite-13C,d1 / 否
HY-W042357S6 Ac-rC Phosphoramidite-13C9,15N3 / 否
HY-W044285 Fmoc-D-4-Aph(cBm)-OH / 否
HY-W048674 Fmoc-Ser(Ac)-OH 97.40% 否
HY-W101384 Ac-D-2-Nal-OH 99.93% 否
HY-W145531 Neu5GcAc[1Me,478Ac,9N3]-β-SPh / 否
HY-W145540 Galβ(1-3)[Neu5Acα(2-6)]GalNAc-α-pNP / 否
HY-W145548 GlcNPhth[36Bn,4Ac]-β-MP / 否
HY-W145609 Neu5Troc[1Me,4789Ac]α(2-3)Gal[26Bn]-β-MP / 否
HY-W145622 Galβ(1-3)[Neu5Acα(2-6)]GlcNAc-β-pNP / 否
HY-W214058 Ac-2-Nal-OH / 否
HY-W393498 Phenyl 2,4,6-tri-O-acetyl-3-O-allyl-β-D-thiogalactopyranoside / 否
HY-W415798 Ac4GalNAlk / 否
HY-W560922 Piperazine-Ac-OMe / 否
HY-W560961 3',5'-TIPS-N-Ac-Adenosine / 否
HY-W713878 Ac-VDVAD-pNA / 否
HY-W766388 2-Amino-2-deoxyglucose hydrochloride-13C6 / 否
HY-W768178 2-Amino-2-deoxyglucose hydrochloride-13C2 / 否
HY-W854187 2'-Ome-Ac-G Phosporamidite / 否
HY-10658 AC-7954 / 否
HY-108312 Ac-VEID-CHO Inhibitor / 否
HY-110209 AC4 Antagonist / 否
HY-113844 Ac-Gly-Lys-OMe / 否
HY-120278 4-Ethoxyquinazoline / 否
HY-121248 Hydramethylnon Inhibitor / 否
HY-121699 Kibdelone B / 否
HY-129027 Ac-Leu-Gly-Lys(Ac)MCA / 否
HY-129648 AC-7954 free base / 否
HY-13493A AC710 Mesylate Inhibitor / 否
HY-138165 Ac-Phe-NH2 / 否
HY-154036 5′-DMTr-dC (Ac)-Methylphosphonamidite / 否
HY-154829 AC-099 Agonist / 否
HY-157171 Ac-YR-NH2 Modulator / 否
HY-157232 AC Antibody purification resin 2 / 否
HY-157233 AC Antibody purification resin 1 / 否
HY-157234 AC mAb-X purification resin / 否
HY-157235 AC Antibody affinity resin / 否
HY-158792 GK241 / 否
HY-161021 AC2 selective-IN-1 / 否
HY-161913 AC-4-248 Inhibitor / 否
HY-162159 Ac-Cys-NHMe / 否
HY-163106 W000113414_I13 Agonist / 否
HY-164053 MicroRNA modulator-1 Modulator 99.58% 否
HY-164249 DMT-rG(Ac) / 否
HY-164253 TBS-rG(Ac) / 否
HY-171289 Neu5Acα2-6GalNAcα1-4GlcNac / 否
HY-171463 AC-271337 / 否
HY-171489 Mal-VC-PAB-EDA-N-Ac-Calicheamicin / 否
HY-19647 Ritipenem acoxil Inhibitor / 否
HY-20560 (Ac)Phe-Lys(Alloc)-PABC-PNP / 否
HY-43565C (1S,9R)-Ac-Exatecan / 否
HY-N12336 Gnetuhainin I / 否
HY-N12894 (Z,E)-7,11-Hexadecadienyl acetate / 否
HY-N12920 (Z)-3-Dodecenyl acetate / 否
HY-P10336 Serpinin Agonist / 否
HY-P10639A C5aR2 agonist P32 acetate Agonist / 否
HY-P10657 Ac-DEMEEC-OH Inhibitor / 否
HY-P10666 Ac-VDQQD-pNA / 否
HY-P10668 Ac-EVKKQR-pNA Inhibitor / 否
HY-P3234 Ac-ESMD-CHO Inhibitor / 否
HY-RS17212 Muc5ac Mouse Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS23664 Muc5ac Rat Pre-designed siRNA Set A Pre-designed Set / 否
HY-W042357 Ac-rC Phosphoramidite 98.87% 否
HY-W129441 N-Acetyl-4-S-cysteaminylphenol / 否
HY-W130878 4-Octylphenol Activator / 否
HY-W131753 2'-F-Ac-C 99.64% 否
HY-W338079 Ac-Asp-Glu-Val-Asp-pNA Substrate / 否
HY-W415799 (2S)-Ac4GalNAl / 否
HY-W780787 (E,Z)-3,13-Octadecadienyl acetate / 否
HY-W783407 Ac-rG Phosporamidite / 否
HY-W881463 N4-Ac-C-(S)-GNA phosphoramidite / 否
HY-P1734 Ac-MBP (1-11) / 否
抗体抑制剂 (2)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-P99715 Losatuxizumab Inhibitor 99.44% 否
HY-P991512 SGN-30 Inducer / 否

直系同源

种属 基因名 来源 基因 ID
Homo sapiens Acly NCBI NCBI:47
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z